Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Custom Research Competitive Landscape Industry News FAQ
On This Report

Self-expanding Stents Market Size & Growth Forecast 2027–2036, By Segments (End-Use, Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14812| Published Date: Aug-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Self-expanding Stents Market size was assessed at USD 3.69 billion in 2026 and is poised to grow at a 3.69% CAGR between 2027 and 2036, reaching USD 5.3 billion by 2036. The industry revenue for 2027 is calculated at USD 3.82 billion.

Base Year Value (2026)
USD 3.69 billion
CAGR (2027-2036)
3.69%
Forecast Year Value (2036)
USD 5.3 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Self-expanding Stents Market Intelligence Snapshot

Regional Market Dynamics

  • North America led the market in 2026 with established interventional care pathways, widespread catheter-based procedures, and routine use of advanced vascular devices across specialized treatment centers.
  • Asia Pacific is projected to grow at a 4.67% CAGR, supported by expanding minimally invasive procedures, improving vascular treatment access, and increasing interventional capabilities across healthcare systems.

Segment Momentum

  • Hospitals lead due to their role in managing complex vascular cases requiring advanced imaging, specialist teams, and comprehensive perioperative care infrastructure for high-risk procedures.
  • ASCs are growing as more minimally invasive stent procedures shift to outpatient settings, offering shorter stays, efficient workflows, and cost-effective care for suitable cases.

Market Expansion Drivers

  • Rising prevalence of cardiovascular diseases increasing demand for minimally invasive stent procedures.
  • Technological advancements in flexible and conformable stent designs improving patient treatment outcomes.
  • Expanding aging population and sedentary lifestyles strengthening long-term demand for vascular interventions.

Leading Market Participants

  • Major companies in the self-expanding stents market include Abbott Laboratories (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Cook Medical LLC (U.S.), Edwards Lifesciences Corporation (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 3.69 billion
  • 2027 Estimated Market Size: USD 3.82 billion.
  • Projected Market Size: USD 5.3 billion by 2036
  • Growth Forecast: 3.69% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End-Use) | Carotid Self-Expanding Stents (Product) | Carotid Artery (Application)
  • Emerging Opportunity Segment: Ambulatory Surgical Centers (End-Use) | Endovascular Self-Expandable Stents (Product) | Biliary (Application)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of cardiovascular diseases increasing demand for minimally invasive stent procedures

The rising burden of cardiovascular diseases is supporting greater adoption of minimally invasive vascular interventions, as patients and healthcare providers increasingly seek effective treatments with reduced procedural trauma and recovery requirements. In this environment, the self-expanding stents market is benefiting from the growing need to restore and maintain blood flow in narrowed or obstructed vessels, particularly in peripheral and other vascular applications where precise stent deployment is important. Self-expanding designs can accommodate vessel movement and changes in diameter after placement, making them suitable for anatomically challenging treatment areas. Increasing clinical reliance on catheter-based procedures is also encouraging healthcare facilities to expand their capabilities for less invasive vascular care, supporting demand for stent technologies used across a broader range of cardiovascular interventions.

Technological advancements in flexible and conformable stent designs improving patient treatment outcomes

Advances in stent engineering are placing greater emphasis on flexibility, conformability, radial support, and controlled deployment to address complex vascular anatomies. The self-expanding stents market is gaining from these improvements as newer designs can better adapt to vessel curvature and movement while maintaining sufficient support against vessel recoil. Enhanced material selection, refined geometries, and improved delivery systems are helping physicians navigate difficult lesions and achieve more precise placement during minimally invasive procedures. Greater attention to vessel compatibility can also help support treatment in locations exposed to mechanical stress, where excessive rigidity may affect device performance, while improved deliverability can make procedures more manageable for clinicians.

Expanding aging population and sedentary lifestyles strengthening long-term demand for vascular interventions

Demographic aging and lifestyle patterns associated with physical inactivity are contributing to a larger population requiring ongoing vascular assessment and intervention. For the self-expanding stents market, this expanding patient pool creates demand for devices capable of treating vessel narrowing and maintaining blood flow in patients who may require minimally invasive alternatives to more invasive surgical approaches. Older populations are particularly associated with a higher likelihood of developing vascular conditions that require long-term clinical management, while sedentary lifestyles can contribute to risk factors linked with vascular disease. As healthcare systems increasingly focus on early diagnosis, disease management, and less invasive treatment pathways, the use of vascular intervention technologies is becoming more relevant across routine and complex patient care.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of cardiovascular diseases 1.30% Short term (≤ 2 yrs) North America, Europe Medium Fast
Technological advancements in self-expanding stent designs 1.40% Medium term (2–5 yrs) North America, Asia Pacific Low Moderate
Expansion of interventional cardiology infrastructure in emerging markets 1.40% Long term (5+ yrs) Asia Pacific, Latin America Low Slow
Rising prevalence of cardiovascular diseases increasing demand for minimally invasive stent procedures 1.90% High North America, Europe High Near Term
Technological advancements in flexible and conformable stent designs improving patient treatment outcomes 1.60% High Asia Pacific, North America Medium Mid Term
Expanding aging population and sedentary lifestyles strengthening long-term demand for vascular interventions 1.30% Moderate Europe, Asia Pacific High Long Term

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Self-expanding Stents Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

The self-expanding stents market was led by North America in 2026, supported by advanced healthcare infrastructure, established interventional treatment capabilities, and strong adoption of minimally invasive vascular procedures. The region benefits from access to sophisticated medical technologies and experienced clinical expertise, while increasing demand for effective treatment of vascular conditions encourages the use of self-expanding stent technologies. Continued investment in advanced cardiovascular care further reinforces regional market leadership.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing regional market, driven by expanding healthcare infrastructure, improving access to interventional procedures, and rising awareness of minimally invasive treatment options. Increasing healthcare investment and the modernization of hospitals are supporting wider availability of advanced vascular technologies. Growing patient demand for effective cardiovascular care, particularly across rapidly developing healthcare systems, is also encouraging adoption of self-expanding stents.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
🔒 Need data on a specific country or region?. Individual country/region reports are available at discounted pricing. Inquire Before Buying
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Device Development

Germany emphasizes high-quality self-expanding stent technologies supported by strong medical device engineering capabilities. Hospitals are adopting innovative stent designs that improve deployment accuracy and treatment outcomes for complex vascular conditions.

France 🇫🇷

Specialized Vascular Procedures

France continues to adopt self-expanding stents across specialized vascular and endovascular interventions. Healthcare providers are emphasizing clinically validated devices that support dependable deployment and consistent patient outcomes during minimally invasive procedures.

Italy 🇮🇹

Hospital Procedure Optimization

Italy is incorporating self-expanding stents into hospital initiatives focused on improving vascular intervention efficiency. Clinicians are selecting devices that offer reliable expansion characteristics and compatibility with evolving minimally invasive treatment protocols.

Japan 🇯🇵

Minimally Invasive Preference

Japan is expanding the use of self-expanding stents as clinicians increasingly favor minimally invasive treatment approaches. Medical institutions are adopting devices that enhance procedural precision while supporting efficient patient recovery pathways.

South Korea 🇰🇷

Clinical Technology Adoption

South Korea is strengthening the self-expanding stents market through investments in advanced interventional procedures and modern healthcare facilities. Medical device suppliers are introducing next-generation stent technologies designed to improve treatment reliability and physician confidence.

United States 🇺🇸

Advanced Interventional Care

The U.S. continues to strengthen demand for self-expanding stents through minimally invasive cardiovascular and peripheral vascular procedures. Healthcare providers are adopting advanced stent technologies that improve procedural efficiency and long-term clinical performance.

Segment Analysis

Segment Leadership and Growth Trends

Self-expanding Stents Market Share (%), by End-Use, 2026

Hospitals
Ambulatory Surgical Centers
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

End-Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

The hospitals segment dominated the self-expanding stents market in 2026, owing to the broad range of complex vascular procedures performed in hospital settings and the availability of specialized clinical infrastructure. Hospitals are equipped to manage patients requiring advanced intervention, continuous monitoring, and multidisciplinary care, supporting the use of self-expanding stents across procedures involving more complex vascular conditions. Established procedural capabilities and access to specialized healthcare professionals further reinforce hospitals as a major setting for stent-based interventions.

The ambulatory surgical centers segment is anticipated to witness the fastest growth, supported by the broader shift toward efficient outpatient care and procedures that can be performed without prolonged hospital stays. Ambulatory surgical centers offer a focused care environment that can support procedural efficiency, lower infrastructure requirements, and faster patient throughput for suitable interventions. As minimally invasive vascular procedures become increasingly compatible with outpatient treatment models, these facilities are positioned to gain a larger role in the adoption of self-expanding stent technologies.

Product Segment Analysis: Carotid Self-Expanding Stents (Largest Segment) vs Endovascular Self-Expandable Stents (Fastest-Growing Segment)

Carotid self-expanding stents represented the largest share of the self-expanding stents market in 2026, supported by their role in maintaining vessel patency during carotid interventions. Their self-expanding design enables the stent to conform to the treated vessel while providing structural support, making these devices important in procedures addressing carotid artery narrowing. Continued emphasis on minimally invasive vascular treatment and the need for reliable stent deployment contribute to the established position of carotid self-expanding stents within the product landscape.

Endovascular self-expandable stents are expected to record the fastest growth, driven by the expanding application of minimally invasive approaches across vascular interventions. Their ability to provide vessel support through catheter-based procedures aligns with the broader preference for less invasive treatment techniques and efficient procedural management. Growing utilization of endovascular approaches can create additional opportunities for these stents as clinicians seek devices that combine flexibility, deployment efficiency, and sustained vessel support across suitable vascular procedures.

Segment Sub-Segment Largest Segment Fastest Growing
End-Use Hospitals, Ambulatory Surgical Centers, Others Hospitals Ambulatory Surgical Centers
Product Carotid Self-Expanding Stents, Gastrointestinal Self-Expanding Stents, Endovascular Self-Expandable Stents, Others Carotid Self-Expanding Stents Endovascular Self-Expandable Stents
Application Fem-Pop Artery, Iliac Artery, Carotid Artery, Biliary, Other Carotid Artery Biliary
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the self-expanding stents market:

1. Abbott Laboratories (U.S.)

2. Medtronic plc (Ireland)

3. Boston Scientific Corporation (U.S.)

4. Becton Dickinson and Company (U.S.)

5. Terumo Corporation (Japan)

6. BIOTRONIK SE & Co. KG (Germany)

7. Cook Medical LLC (U.S.)

8. Edwards Lifesciences Corporation (U.S.)

9. Stryker Corporation (U.S.)

10. B. Braun Melsungen AG (Germany)

Continuous advancements in minimally invasive medical technologies are enhancing treatment outcomes in vascular procedures. The self-expanding stents market is witnessing innovation in material design and deployment mechanisms that improve flexibility and clinical performance. Increasing focus on precision and patient-specific treatment approaches is driving development of next-generation solutions. The self-expanding stents market continues to evolve with strong emphasis on improving procedural efficiency and long-term vascular support.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Abbott Laboratories (U.S.)
Medtronic plc (Ireland)
Boston Scientific Corporation (U.S.)
Becton Dickinson and Company (U.S.)
Terumo Corporation (Japan)
BIOTRONIK SE & Co. KG (Germany)
Cook Medical LLC (U.S.)
Edwards Lifesciences Corporation (U.S.)
Stryker Corporation (U.S.)
B. Braun Melsungen AG (Germany).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Boston Scientific Aug-25 Boston Scientific initiated a recall of selected carotid stents after identifying a manufacturing defect. The issue raised concerns regarding potential vessel damage, compromised stent integrity, and debris release, highlighting quality control and patient safety risks within the self-expanding stents market and reinforcing regulatory scrutiny on device reliability.
Reflow Medical May-25 Reflow Medical received FDA de novo clearance for its Spur Peripheral Retrievable Stent System. The approval enables commercialization of a novel retrievable stent technology, enhancing treatment flexibility in peripheral vascular interventions and strengthening innovation-driven competition in the self-expanding stents segment.
Teleflex Feb-25 Teleflex agreed to acquire Biotronik’s vascular intervention business for EUR 760 million. The transaction expands Teleflex’s vascular device portfolio and strengthens its position in self-expanding stents and related intervention technologies, supporting broader scale and competitive positioning in the global vascular access and treatment market.
Merit Medical Dec-24 Merit Medical received FDA premarket approval for its WRAPSODY Endoprosthesis, with U.S. commercialization planned for 2025. The approval strengthens its interventional portfolio and supports expansion in venous and vascular disease treatment, enhancing competitive presence in the self-expanding stents market through regulatory-backed product advancement.
Philips Jun-24 Philips launched a venous stent system developed through its acquisition of Vesper Medical, expanding its vascular intervention portfolio. The product targets restoration of blood flow in blocked veins and reflects Philips’ strategy of commercializing acquired technologies to strengthen its position in the venous disease treatment segment.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Self-expanding Stents Market — Custom Segments

Segment Sub-Segment
Material Nitinol, Cobalt-Chromium, Stainless Steel
Procedure Type Endovascular Procedures, Surgical Procedures, Endoscopic Procedures
Disease Indication Peripheral Artery Disease, Carotid Artery Disease, Aortic & Venous Disorders, Gastrointestinal Disorders

Self-expanding Stents Market — Custom TOC

Custom Chapter Chapter Details
Clinical Adoption and Procedure Trends
  • Procedure Volume and Clinical Application Trends
  • Adoption Patterns Across Key Indications and Care Settings
  • Regional Variations in Clinical Utilization
  • Evolving Treatment Preferences and Procedural Practices
Reimbursement and Market Access Strategy
  • Reimbursement Coverage and Payment Environment
  • Payer Policies and Access Barriers
  • Health Economics and Value Demonstration
  • Market Access Pathways and Commercial Implications
Hospital Procurement and Tendering Dynamics
  • Hospital Purchasing Criteria and Decision Drivers
  • Tendering Models and Procurement Processes
  • Institutional Supplier Evaluation and Contracting Priorities
  • Procurement Trends and Commercial Opportunity Areas

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current revenue of the self-expanding stents market?

In 2027 the market for self-expanding stents is worth approximately USD 3.82 billion.

What is the projected value of the self-expanding stents industry by 2036?

Self-expanding Stents Market size was assessed at USD 3.69 billion in 2026 and is poised to grow at a 3.69% CAGR between 2027 and 2036, reaching USD 5.3 billion by 2036.

How is the rising burden of cardiovascular disease influencing demand for self-expanding stent procedures?

Increasing cardiovascular disease prevalence is shifting treatment toward minimally invasive endovascular interventions, driving higher utilization of self-expanding stents that support flexible navigation, vessel support, and reduced surgical recovery requirements.

How are demographic shifts shaping long-term adoption of self-expanding stents?

Aging populations and lifestyle-related vascular conditions are expanding the patient base requiring intervention, increasing reliance on stents for fragile, complex vessels where minimally invasive approaches offer more practical long-term treatment pathways.

Why do hospitals account for the largest share in the self-expanding stents market?

Hospitals lead due to their role in managing complex vascular cases requiring advanced imaging, specialist teams, and comprehensive perioperative care infrastructure for high-risk procedures.

Why are ambulatory surgical centers the fastest-growing end-use segment?

ASCs are growing as more minimally invasive stent procedures shift to outpatient settings, offering shorter stays, efficient workflows, and cost-effective care for suitable cases.

What supports North America's leadership in the self-expanding stents market?

North America led the market in 2026 with established interventional care pathways, widespread catheter-based procedures, and routine use of advanced vascular devices across specialized treatment centers.

Why is Asia Pacific the fastest-growing market for self-expanding stents?

Asia Pacific is projected to grow at a 4.67% CAGR, supported by expanding minimally invasive procedures, improving vascular treatment access, and increasing interventional capabilities across healthcare systems.

Which companies are driving growth in the self-expanding stents landscape?

Major companies in the self-expanding stents market include Abbott Laboratories (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Cook Medical LLC (U.S.), Edwards Lifesciences Corporation (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Read our Research Approach →

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →